Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer.

Barger CJ, Branick C, Chee L, Karpf AR
Cancers (Basel). 2019 Feb 21;11(2). pii: cancers11020251. doi: 10.3390/cancers11020251. PubMed Article

Plasmids from Article

ID	Plasmid	Purpose
71782	pCW57-MCS1-2A-MCS2	All-in-one doxycycline inducible lentiviral vector for expression of one or two genes using the P2A self-cleaving peptide.
71783	pCW57-GFP-2A-MCS	All-in-one doxycycline inducible lentiviral vector for expression of one gene in combination with turbo GFP using the P2A self-cleaving peptide.
78933	pCW57-RFP-P2A-MCS	All-in-one doxycycline inducible lentiviral vector for expression of one gene in combination with turbo RFP using the P2A self-cleaving peptide.
80921	pCW57-MCS1-P2A-MCS2 (Blast)	All-in-one doxycycline inducible lentiviral vector for expression of one or two genes using the P2A self-cleaving peptide.
80922	pCW57-MCS1-P2A-MCS2 (Hygro)	All-in-one doxycycline inducible lentiviral vector for expression of one or two genes using the P2A self-cleaving peptide.
80923	pCW57-MCS1-P2A-MCS2 (RFP)	All-in-one doxycycline inducible lentiviral vector for expression of one or two genes using the P2A self-cleaving peptide.
80924	pCW57-MCS1-P2A-MCS2 (GFP)	All-in-one doxycycline inducible lentiviral vector for expression of one or two genes using the P2A self-cleaving peptide.
87360	TLCV2	LentiCRISPR v2 was modified into an all-in-one dox inducible system. The addition of doxycycline induces Cas9-2A-eGFP. The U6 promoter drives constitutive sgRNA expression.
87836	TLCV2-RB1	LentiCRISPR v2 was modified into an all-in-one dox inducible system. The addition of doxycycline induces Cas9-2A-eGFP. The U6 promoter drives constitutive expression of an sgRNA targeting human RB1.